█ INTRODUCTION
Glioblastoma (GBM) is the most common and the most aggressive primary brain tumor with a poor prognosis (14) . The average survival is 12-15 months, despite advances in chemotherapy, radiotherapy (RT) and surgery (3, 10) . Due to the tendency of tumor cells to spread rapidly to surrounding tissues, tumor cells can escape from surgical excision. Additionally, because of their increased resistance to apoptosis, they are resistant to radiation and chemotherapy too (7) . Both chemotherapy and RT can give rise to deoxyribonucleic involves the regulation of angiogenesis and chemo-resistance (20) . Survivin is normally expressed in fetal tissue but is absent in most of the differentiated adult cells (1). Tumors that highly express survivin generally have an aggressive behavior and poor prognosis and are associated with resistance to RT and chemotherapy (33) .
Angiogenesis is defined as the formation of new capillaries from the pre-existing vascular network. Increased angiogenesis is correlated with tumor growth and metastasis in different tumor types (8) . Methods for evaluation of angiogenesis including microvessel density (MVD) and vascular pattern have been used in most of the prognostic studies (9, 21) .
In this study, we aimed to evaluate the association between immunohistochemical expression of survivin and angiogenic parameters (MVD and vascular pattern) in patients who underwent surgery for GBM. █ 
MATERIAL and METHODS

Patients and Clinicopathological Analysis
The data of the patients who underwent surgery for a brain tumor between 2000 and 2012 at Trakya University Medical Faculty, and were diagnosed as GBM in the Department of Pathology, were reviewed. The patients, who underwent total tumor excision as confirmed with postoperative radiological examination, were included in this study. The pathology reports and also clinical and follow-up data of the patients were retrospectively evaluated. Tumor slides of all patients were re-evaluated ( Figure 1A-D) . The local ethics committee approved the study design (Trakya University No.152/2014-17/10).
Immunohistochemical Analysis
Control tissues (from data sheets) were obtained from the archive for each antibody. Then, control staining of these 
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antibodies was performed. Staining for survivin and CD34 antibodies was performed with a fully automated immunohistochemistry and in situ hybridization (IHC/ISH) staining machine (Ventana BenchMark XT, USA). The following primary antibodies at the indicated dilutions were used for IHC: rabbit polyclonal anti-survivin (NB-500-201 K3, 1:500; Novus Biological Inc., USA) and CD34 (1:100, monoclonal, Neomarkers, USA).
Survivin Evaluation
For survivin antibody, immunoexpression was based on the percentage of positively stained cells, after counting at least 1000 cells (19 (32) .
MVD Evaluation
For MVD assessment; areas of tumor containing the highest number of capillaries and small venules were chosen at low power field (40× and 100×) by light microscopy. Tumors exhibited heterogeneous pattern of MVD, but the areas having the highest neovascularization were found and CD 34 antibody was used to identify the areas of invasive carcinoma with the highest number of discrete microvessels. Any brown-staining endothelial cell or cell cluster that was clearly separate from adjacent microvessels, tumor cells, and other connective tissue elements was considered a single, countable microvessel. Vessel lumens, although usually present, were not necessary for a structure to be defined as a microvessel, and red blood cells were not used to define a vessel lumen. Vessel count was performed on x200 field in five areas and the average value was determined statistically (30).
Vascular Pattern
Angiogenic subtypes were evaluated on CD34-immunostained tissue sections. Vessels were evaluated according to an algorithm described by Preusser et al. (23) . This method was described for the standardized assessment of vascular pattern.
Firstly, the presence of delicate network of branching capillaries throughout the tumor was evaluated as yes/no and was described as score A (not present: 0, present: 1).
In the second step, the presence of vascular clusters (score B1), vascular garlands (score B2) or glomeruloid vascular formations (score B3) were evaluated as none: 0, few/discrete: 1, many/prominent: 2. Then, score B was calculated as the sum of them (Score B = score B1 + score B2 + score B3). Finally, the vascular pattern was calculated from scores A and B following this algorithm (If score A = 1 and score B = 2, then "classic vascular pattern". If score A = 0 or score B > 2, then "bizarre vascular pattern").
Statistical Analysis
Demographic-clinical characteristic of patients were shown as mean ± standard error of mean (SEM) and percentages. (Figure 2A, B) . And there was a significant negative correlation between survivin staining and survival time, with the survival time of patients decreasing with increasing score of survivin staining (r= -0.656, p=0.000) (Table II) .
Patients were classified in two groups based on MVD. Group 1 consisted of tumors with MVD count <70%, group 2 consisted of tumors with MVD ≥70%. Mean survival time for group 1 was 12.00±3.26 months and for group 2 it was 11.616±1.31 months. There was no significant difference between survival time of groups (p>0.05). There was no significant correlation between MVD and survival time (r=-0.490, p=0.667). There was also no significant correlation between survivin IHC expression and MVD (r= 0.023, p=0.843) (Table II) .
Patients with secondary GBM had longer survival time than primary GBM and this difference was statically significant (p=0.048). There was no relationship between tumor location and survival (p>0.05). There was also no significant correlation between survival times and gender (p=0.68). pattern was an independent prognostic factor in GBMs. They stated that while the bizarre vascular pattern was related with shorter survival times, the classic vascular pattern was related with higher survival rates. There were statistically significant results for vascular patterns in our study, similar to the previous results.
Sharma et al. (28) showed that increased angiogenesis was characterized with an increased number of disproportionate size and irregular vessels in GBMs. They did not show relationship between angiogenic features and proliferation. Even though they observed glomeruloid proliferation in GBMs, their study's follow-up data were not adequate for precise results (15) . Recently Preusser et al. (24) evaluated the influence of MVD and vascular patterns on GBM patients' survival. In this study, inter-observer differences were high in choosing the hot spot area. They also repeatedly assessed MVD and vascular patterns in two GBM series. They showed that there was no association between MVD, vascular patterns and patient outcomes. They concluded that inter-observer difference was a limiting factor for the clinical utility of hot-spot MVD and vascular patterns as prognostic factors in GBMs.
Onguru et al. (21) stated that these methods were questionable, because of regional heterogeneity in the vascularization of GBMs. We agree with Onguru et al. and we thought that the MVD was an independent factor for prognosis. It can be evaluated in only vascular areas of partial sampled tumors and this condition may affect the histopathological evaluation of tumor because of the tumor heterogeneity and inadequate specimen. Therefore, only totally resected tumors were included in our study.
De novo GBMs have similar aggressive features. The special glomeruloid vascular pattern was more effective on survival than MVD. The special histopathological vascular features of GBM and methodological differences can also affect these results. We thought that our findings might represent an important effect on patient management. Our study showed that there is no association between MVD and patient's clinical outcome. However, new studies with stereological or neuroradiological methods should be planned with large series. Survivin is a member of IAPs. Survivin is known to be normally highly expressed in fetal tissue but absent in normal adult cells (1). It is expressed extensively in a lot of human cancers (1, 16) and the increased expression of survivin appears to be associated with the poor prognosis and aggressive behavior of the tumors. GBM is an example of these tumors. Especially, the survivin expression is correlated with the survival of patients. Some authors have reported increased cytoplasmic expression in human gliomas. The degree of immunoexpression of survivin in gliomas was correlated with the increase in the pathological grade of tumor (11, 26) . In addition, patients who had been diagnosed as GBM, with detectable survivin expression, have been observed to have significantly shorter survival time (6) . Based on these results, it can be suggested that survivin might be involved in tumorigenesis and progression of GBM (32) . So, survivin would be useful to predict the prognosis and it may be a target gene for the new therapeutic agents. Hence, survivin inhibition might enable the elimination of GBM without affecting normal tissue (2, 17, 34).
Some studies showed a relationship between survivin expression and radiation resistance in some malignancies. Chakravarti et al. (6) reported that survivin suppresses radiation-induced cell death because it improves doublestrand DNA break repair in tumor cells. Sasaki et al. (26) showed that suppression of survivin by small interfering ribonucleic acid (RNA)(siRNA) improved radiosensitivity of tumor cells. Based on these findings, anti-survivin therapies may enhance the radiation response, and be correlated with better results (12, 13, 26) .
GBM has been a major candidate for anti-angiogenic treatment because of its prominent neovascularization (22) . Some studies have found a close relation between MVD and prognosis of GBMs (5, 28, 31) . The vascular pattern may also have an important role on the efficacy of anti-angiogenic therapy. Evaluation of the microvascular features of GBMs can help enable the use of anti-angiogenic drugs (4, 5) . However, there are no validated drugs that can be used to determine the angiogenic features of GBM in relation to anti-angiogenic therapies. There is also no data on the threat of the angiogenic part of the tumor (24).
In our study, results of survivin staining supported that survivin was highly expressed in GBMs. Survivin expression was seen in tumors without a significant relationship with MVD. The difference of survivin expression between the bizarre and classical vascular patterns in GBMs was statistically significant.
A few studies showed that bizarre vascular pattern was an independent prognostic factor in GBMs. Bernsen et al. (4) showed that the presence of a low amount of bizarre vascular pattern with a high amount of classical vascular pattern together in GBM was an independent factor for high survival rate. Also, Preusser et al. (24) reported that the more vascular
